OBAM
RPRX icon

ODDO BHF Asset Management’s Royalty Pharma RPRX Stock Holding History

ODDO BHF Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52,755
Closed -$1.86M – 387
2025
Q3 		$1.86M Sell
52,755
-8,229
-13% -$298K 0.07% 203
2025
Q2 		$2.2M Sell
60,984
-4,305
-7% -$143K 0.09% 207
2025
Q1 		$2.03M Buy
+65,289
New +$2.07M 0.08% 227

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ODDO BHF Asset Management's RPRX Position: Q4 2025 in Review

ODDO BHF Asset Management sold out of Royalty Pharma (RPRX) in Q4 2025, closing a stake of 52,755 shares — an estimated $1.86M sold.

ODDO BHF Asset Management first reported a position in RPRX in Q1 2025 and held it in 3 quarters. The position peaked at $2.2M in Q2 2025. 538 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

  • ODDO BHF Asset Management reported no remaining Royalty Pharma position as of Q4 2025 after selling out during the quarter.
  • ODDO BHF Asset Management sold 52,755 Royalty Pharma shares in Q4 2025, an estimated $1.86M.
  • ODDO BHF Asset Management first reported a position in Royalty Pharma in Q1 2025 and held it in 3 quarters.
  • ODDO BHF Asset Management's Royalty Pharma position peaked at $2.2M in Q2 2025.
  • 538 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on ODDO BHF Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.